You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pulmonary Fibrosis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial (Ifetroban Sodium, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ifetroban Sodium
  • Placebo
  • (no location specified)
Jan 25, 2023

Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Jan 3, 2023

Pulmonary Fibrosis Trial (A wearable cough monitoring device, the Strados Labs RESP?? sensor, with an accompanying mobile

Not yet recruiting
  • Pulmonary Fibrosis
  • A wearable cough monitoring device, the Strados Labs RESPᵀᴹ sensor, with an accompanying mobile application (App) for data collection
  • (no location specified)
Jan 9, 2023

Explanted Lung Tissues With Pulmonary Fibrosis

Recruiting
  • Pulmonary Fibrosis
    • Chicago, Illinois
      The University of Chicago
    Nov 18, 2022

    Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study

    Not yet recruiting
    • Pulmonary Fibrosis
    • COVID-19
    • observational study
    • Kunming, Yunnan, China
    • +1 more
    Feb 7, 2023

    Idiopathic Pulmonary Fibrosis Trial in London (LTI-03, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • London, United Kingdom
      Study Site
    Jul 18, 2023

    Respiratory Muscle Strength in Idiopathic Pulmonary Fibrosis

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • no intervention - cross-sectional observational only
    • Istanbul, Zeytinburnu, Turkey
      Yedikule Chest Disease Hospital
    Nov 4, 2022

    Pulmonary Fibrosis Trial (Oxygen Nanobubble, Placebo)

    Not yet recruiting
    • Pulmonary Fibrosis
    • Oxygen Nanobubble
    • Placebo
    • (no location specified)
    Jan 30, 2023

    Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (Saracatinab, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Denver, Colorado
    • +3 more
    Jan 27, 2023

    Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Systemic Sclerosis With Lung Involvement
    • El Paso, Texas
      El Paso Pulmonary Association Elligo PPDS
    Mar 14, 2023

    Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (INS018_055, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Los Angeles, California
    • +8 more
    Jul 27, 2023

    Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Adelaide, South Australia, Australia
      Research Site
    Apr 5, 2023

    Progressive Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)

    Not yet recruiting
    • Progressive Pulmonary Fibrosis
    • Stanford, California
    • +7 more
    Sep 11, 2023

    Idiopathic Pulmonary Fibrosis Trial in Adelaide (SRN-001, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Adelaide, South Australia, Australia
      CMAX Clinical Research
    Aug 2, 2023

    Idiopathic Pulmonary Fibrosis Trial in Tours (intrapulmonary percussive ventilation, delivery of 99mTc-DTPA aerosol)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • intrapulmonary percussive ventilation
    • delivery of 99mTc-DTPA aerosol
    • Tours, France
      Pulmonology Department, University Hospital, Tours
    Dec 7, 2022

    Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • nalbuphine ER
    • Placebo
    • (no location specified)
    Jul 19, 2023

    Advancing Prevention of Pulmonary Fibrosis

    Recruiting
    • IPF
    • +2 more
    • Sample collection
    • +3 more
    • Aurora, Colorado
      University of Colorado Anschutz Medical Campus
    Aug 18, 2022

    Covid19, Pulmonary Fibrosis Interstitial Trial in Cairo (Colchicine 0.5 MG, the standard protocol only)

    Active, not recruiting
    • Covid19
    • Pulmonary Fibrosis Interstitial
    • Colchicine 0.5 MG
    • the standard protocol only
    • Cairo, Egypt
      El-Demerdash Hospital
    Nov 6, 2022

    Idiopathic Pulmonary Fibrosis, IPF Trial in Izmir (Inspiratory Muscle Training (IMT), Sham IMT)

    Completed
    • Idiopathic Pulmonary Fibrosis
    • IPF
    • Inspiratory Muscle Training (IMT)
    • Sham IMT
    • Izmir, Balcova, Turkey
      Dokuz Eylul University
    Nov 6, 2022

    IPF Trial in China (PMG1015, PMG1015 )

    Recruiting
    • IPF
    • Beijing, Beijing, China
    • +5 more
    May 31, 2023

    Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Aug 23, 2022

    Idiopathic Pulmonary Fibrosis (IPF) Trial in China, United States (INS018_055, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Los Angeles, California
    • +9 more
    Jul 6, 2023

    Analysis of Specimens From Individuals With Pulmonary Fibrosis

    Recruiting
    • Pulmonary Fibrosis
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Idiopathic Pulmonary Fibrosis Trial in Australia, United States (PLN-74809, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Redding, California
      • +15 more
      Oct 18, 2023

      Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

      Completed
      • Idiopathic Pulmonary Fibrosis
      • Milton, Massachusetts
        Medicus Economics, LCC
      Aug 8, 2022